Lundbeck
HLUN-B.CO
#2346
Rank
A$9.80 B
Marketcap
$10.13
Share price
0.98%
Change (1 day)
21.37%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Net assets

Net assets on the balance sheet as of June 2024 : A$5.01 B

According to Lundbeck 's latest financial reports the company has A$5.01 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Lundbeck - Net assets on balance sheet (from 2009 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$A$4.79 B8.98%
2022-12-31$A$4.39 B14.89%
2021-12-31$A$3.82 B5.12%
2020-12-31$A$3.64 B1.72%
2019-12-31$A$3.57 B15.53%
2018-12-31$A$3.09 B23.18%
2017-12-31$A$2.51 B32.1%
2016-12-31$A$1.90 B7.74%
2015-12-31$A$1.76 B-34.4%
2014-12-31$A$2.69 B-3.72%
2013-12-31$A$2.79 B23.97%
2012-12-31$A$2.25 B3.98%
2011-12-31$A$2.17 B10.72%
2010-12-31$A$1.96 B3.4%
2009-12-31$A$1.89 B-7.16%
2008-12-31$A$2.04 B26.91%
2007-12-31$A$1.60 B5.75%
2006-12-31$A$1.52 B-6.14%
2005-12-31$A$1.62 B-12.09%
2004-12-31$A$1.84 B